PAPP-A: a promising therapeutic target for healthy longevity

Cheryl A. Conover, Claus Oxvig

Research output: Contribution to journalReview article

9 Scopus citations

Abstract

Pregnancy-associated plasma protein-A (PAPP-A) is a proteolytic enzyme that was discovered to increase local insulin-like growth factor (IGF) availability for receptor activation through cleavage of inhibitory IGF binding proteins (IGFBPs). Reduced IGF signaling has been associated with increased lifespan and healthspan. Therefore, inhibition of PAPP-A represents a novel approach to indirectly decrease the availability of bioactive IGF. Here, we will review data in support of PAPP-A as a therapeutic target to promote healthy longevity.

Original languageEnglish (US)
Pages (from-to)205-209
Number of pages5
JournalAging Cell
Volume16
Issue number2
DOIs
StatePublished - Apr 1 2017

Keywords

  • IGF
  • PAPP-A
  • aging

ASJC Scopus subject areas

  • Aging
  • Cell Biology

Fingerprint Dive into the research topics of 'PAPP-A: a promising therapeutic target for healthy longevity'. Together they form a unique fingerprint.

  • Cite this